Role of NKCC1 and KCC2 during hypoxia-induced neuronal swelling in the neonatal neocortex
Neonatal hypoxia causes cytotoxic neuronal swelling by the entry of ions and water. Multiple water pathways have been implicated in neurons because these cells lack water channels, and their membrane has a low water permeability. NKCC1 and KCC2 are cation-chloride cotransporters (CCCs) involved in w...
| Published in: | Neurobiology of Disease |
|---|---|
| Main Authors: | Yusuke Takezawa, Rachel Langton, Samuel M. Baule, Miriam Bridget Zimmerman, Stephen Baek, Joseph Glykys |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-03-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S096999612300027X |
Similar Items
Isoflurane-induced neuroinflammation and NKCC1/KCC2 dysregulation result in long-term cognitive disorder in neonatal mice
by: Dongni Xu, et al.
Published: (2024-06-01)
by: Dongni Xu, et al.
Published: (2024-06-01)
Loop diuretics association with Alzheimer’s disease risk
by: Anna Graber-Naidich, et al.
Published: (2023-09-01)
by: Anna Graber-Naidich, et al.
Published: (2023-09-01)
Beta-Amyloid (Aβ<sub>1-42</sub>) Increases the Expression of NKCC1 in the Mouse Hippocampus
by: Patricia Lam, et al.
Published: (2022-04-01)
by: Patricia Lam, et al.
Published: (2022-04-01)
Furosemide prevents membrane KCC2 downregulation during convulsant stimulation in the hippocampus
by: Lulan Chen, et al.
Published: (2022-06-01)
by: Lulan Chen, et al.
Published: (2022-06-01)
Safety, Tolerability, and EEG-Based Target Engagement of STP1 (PDE3,4 Inhibitor and NKCC1 Antagonist) in a Randomized Clinical Trial in a Subgroup of Patients with ASD
by: Craig A. Erickson, et al.
Published: (2024-06-01)
by: Craig A. Erickson, et al.
Published: (2024-06-01)
Effect of furosemide in the treatment of high-altitude pulmonary edema
by: Dava Tenzing, et al.
Published: (2024-03-01)
by: Dava Tenzing, et al.
Published: (2024-03-01)
Hospital preparations of ethanol-free furosemide oral solutions: Formulation and stability study
by: Charles Bavouma Sombie, et al.
Published: (2022-01-01)
by: Charles Bavouma Sombie, et al.
Published: (2022-01-01)
Astrocyte-Conditioned Medium Induces Protection Against Ischaemic Injury in Primary Rat Neurons
by: Ayesha Singh, et al.
Published: (2025-07-01)
by: Ayesha Singh, et al.
Published: (2025-07-01)
Comparative Proteomics Unveils LRRFIP1 as a New Player in the DAPK1 Interactome of Neurons Exposed to Oxygen and Glucose Deprivation
by: Núria DeGregorio-Rocasolano, et al.
Published: (2020-11-01)
by: Núria DeGregorio-Rocasolano, et al.
Published: (2020-11-01)
Bumetanide Therapeutic Effect in Children and Adolescents With Autism Spectrum Disorder: A Review Study
by: Raheleh Mollajani, et al.
Published: (2019-09-01)
by: Raheleh Mollajani, et al.
Published: (2019-09-01)
Delta Opioid Peptide Targets Brain Microvascular Endothelial Cells Reducing Apoptosis to Relieve Hypoxia-Ischemic/Reperfusion Injury
by: Ran Zhang, et al.
Published: (2022-12-01)
by: Ran Zhang, et al.
Published: (2022-12-01)
NKCC1 and KCC2: Structural insights into phospho-regulation
by: Anna-Maria Hartmann, et al.
Published: (2022-07-01)
by: Anna-Maria Hartmann, et al.
Published: (2022-07-01)
Effectiveness of Furosemide Combined with Human Albumin Versus Furosemide Alone in the Management of Edema Among Pediatric Nephrotic Syndrome Patients: An Observational Study
by: Surbhi Nagori, Maneesha Bhargava, Amarjeet Mehta
Published: (2023-12-01)
by: Surbhi Nagori, Maneesha Bhargava, Amarjeet Mehta
Published: (2023-12-01)
In vitro model of ischemic stroke neurons from Macaca fascicularis
by: Ratih Rinendyaputri, et al.
Published: (2025-02-01)
by: Ratih Rinendyaputri, et al.
Published: (2025-02-01)
The landscape of m1A modification and its posttranscriptional regulatory functions in primary neurons
by: Chi Zhang, et al.
Published: (2023-03-01)
by: Chi Zhang, et al.
Published: (2023-03-01)
Repurposed Edaravone, Metformin, and Perampanel as a Potential Treatment for Hypoxia–Ischemia Encephalopathy: An In Vitro Study
by: Daniela Silva, et al.
Published: (2022-11-01)
by: Daniela Silva, et al.
Published: (2022-11-01)
Bumetanide-Enhanced Phenobarbetal in Neonatal Seizure Model
by: J Gordon Millichap
Published: (2008-03-01)
by: J Gordon Millichap
Published: (2008-03-01)
Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease
by: Ben Boyarko, et al.
Published: (2023-08-01)
by: Ben Boyarko, et al.
Published: (2023-08-01)
Construction and Evaluation of Theranostic Near-infrared Fluorescent Probe for Targeting Inflammatory Brain Edema
by: QIN Jing, et al.
Published: (2024-06-01)
by: QIN Jing, et al.
Published: (2024-06-01)
Netrin-1 Prevents Rat Primary Cortical Neurons from Apoptosis via the DCC/ERK Pathway
by: Jianhao Chen, et al.
Published: (2017-12-01)
by: Jianhao Chen, et al.
Published: (2017-12-01)
Nanoformulated Bumetanide Ameliorates Social Deficiency in BTBR Mice Model of Autism Spectrum Disorder
by: Hui Lv, et al.
Published: (2022-05-01)
by: Hui Lv, et al.
Published: (2022-05-01)
Long-term administration of bumetanide improve functional recovery after spinal cord injury in rats
by: Shiva Hashemizadeh, et al.
Published: (2022-10-01)
by: Shiva Hashemizadeh, et al.
Published: (2022-10-01)
Пути решения толерантности к мочегонным лекарственным средствам при лечении отечного синдрома = Decision to tolerance diuretic drugs in the treatment of edematous syndrome
by: I. V. Pogorelaya
Published: (2015-11-01)
by: I. V. Pogorelaya
Published: (2015-11-01)
Dose Response of Bumetanide on Aquaporins and Angiogenesis Biomarkers in Human Retinal Endothelial Cells Exposed to Intermittent Hypoxia
by: Sibel Guzel, et al.
Published: (2021-09-01)
by: Sibel Guzel, et al.
Published: (2021-09-01)
Effect of Co-administration of Bumetanide and Phenobarbital on Seizure Attacks in Temporal Lobe Epilepsy
by: Reza Rahmanzadeh, et al.
Published: (2018-11-01)
by: Reza Rahmanzadeh, et al.
Published: (2018-11-01)
Cation-Chloride Cotransporters KCC2 and NKCC1 as Therapeutic Targets in Neurological and Neuropsychiatric Disorders
by: Patricia Lam, et al.
Published: (2023-01-01)
by: Patricia Lam, et al.
Published: (2023-01-01)
The Anticancer Activity for the Bumetanide-Based Analogs via Targeting the Tumor-Associated Membrane-Bound Human Carbonic Anhydrase-IX Enzyme
by: Azizah M. Malebari, et al.
Published: (2020-09-01)
by: Azizah M. Malebari, et al.
Published: (2020-09-01)
Human Factors Validation of a Wearable, On-Body Infusor for Subcutaneous Administration of Furosemide
by: Andre AD, et al.
Published: (2024-06-01)
by: Andre AD, et al.
Published: (2024-06-01)
Hippocampal and Cortical Pyramidal Neurons Swell in Parallel with Astrocytes during Acute Hypoosmolar Stress
by: Thomas R. Murphy, et al.
Published: (2017-09-01)
by: Thomas R. Murphy, et al.
Published: (2017-09-01)
A Case Report of Gastric Diverticulum-An Uncommon Cause of Dyspepsia
by: Muhamad Amzar, et al.
Published: (2025-01-01)
by: Muhamad Amzar, et al.
Published: (2025-01-01)
NKCC1 and KCC2 Chloride Transporters Have Different Membrane Dynamics on the Surface of Hippocampal Neurons
by: Erwan Pol, et al.
Published: (2023-09-01)
by: Erwan Pol, et al.
Published: (2023-09-01)
EVALUATION OF DOG ELECTROCARDIOGRAPHY IN HYPOKALEMIA
by: Israa Abdul Wadood Mohammad Ali
Published: (2014-12-01)
by: Israa Abdul Wadood Mohammad Ali
Published: (2014-12-01)
Nephrocalcinosis fortuitously discovered: the role of surreptitious self administration of diuretics
by: Nery Sablon Gonzalez, et al.
Published: (2024-01-01)
by: Nery Sablon Gonzalez, et al.
Published: (2024-01-01)
Exit interviews from two randomised placebo-controlled phase 3 studies with caregivers of young children with autism spectrum disorder
by: Natalia Hawken, et al.
Published: (2024-06-01)
by: Natalia Hawken, et al.
Published: (2024-06-01)
A Wholistic View of How Bumetanide Attenuates Autism Spectrum Disorders
by: Eric Delpire, et al.
Published: (2022-08-01)
by: Eric Delpire, et al.
Published: (2022-08-01)
Hydroxyapatite Nanorods Based Drug Delivery Systems for Bumetanide and Meloxicam, Poorly Water Soluble Active Principles
by: Valeria Friuli, et al.
Published: (2024-01-01)
by: Valeria Friuli, et al.
Published: (2024-01-01)
EXPLORING THE ROLE OF THE WNK-SPAK-NKCC1-KCC2 PATHWAY IN THE REGULATION OF NEURONAL ACTIVITY OF THE SUPRACHIASMATIC NUCLEUS
by: Vanessa Isabel Romero Estrada, et al.
Published: (2023-10-01)
by: Vanessa Isabel Romero Estrada, et al.
Published: (2023-10-01)
The SWELL1 Channel Promotes Ischemic Brain Damage by Mediating Neuronal Swelling and Glutamate Toxicity
by: Jianan Chen, et al.
Published: (2024-09-01)
by: Jianan Chen, et al.
Published: (2024-09-01)
5-HMF plays an intervention role in ischemic stroke by regulating GluR2 to improve mitochondrial function and promote angiogenesis
by: Yan Zhang, et al.
Published: (2025-12-01)
by: Yan Zhang, et al.
Published: (2025-12-01)
Apigenin attenuates myocardial ischemia-reperfusion injury through miR-448/SIRT1 axis
by: Chenchen Tian, et al.
Published: (2025-05-01)
by: Chenchen Tian, et al.
Published: (2025-05-01)
Similar Items
-
Isoflurane-induced neuroinflammation and NKCC1/KCC2 dysregulation result in long-term cognitive disorder in neonatal mice
by: Dongni Xu, et al.
Published: (2024-06-01) -
Loop diuretics association with Alzheimer’s disease risk
by: Anna Graber-Naidich, et al.
Published: (2023-09-01) -
Beta-Amyloid (Aβ<sub>1-42</sub>) Increases the Expression of NKCC1 in the Mouse Hippocampus
by: Patricia Lam, et al.
Published: (2022-04-01) -
Furosemide prevents membrane KCC2 downregulation during convulsant stimulation in the hippocampus
by: Lulan Chen, et al.
Published: (2022-06-01) -
Safety, Tolerability, and EEG-Based Target Engagement of STP1 (PDE3,4 Inhibitor and NKCC1 Antagonist) in a Randomized Clinical Trial in a Subgroup of Patients with ASD
by: Craig A. Erickson, et al.
Published: (2024-06-01)
